MoneyWorks4Me

Lyka Labs informs about statement of investor complaints

11 Jan 2018 Evaluate

Lyka Labs has informed that the Company has not received any complaints in respect of its Listed Securities i.e. shares during the quarter ended 31st December, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1737.00
Dr. Reddys Labs. 1236.95
Cipla 1324.90
Lupin 1940.25
Zydus Lifesciences 1117.20
View more..